NYSE:AVNS

Avanos Medical Stock Insider Trading

Healthcare > Medical - Devices

Buy AVNS

*Your capital is at risk

$24.99

+0 (+0%)

At Close: Jul 31, 2026

Avanos Medical Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -12.29. In total, the insiders bought 2.31M and sold 1.35M AVNS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-12.29
● Buy	2.31M shares
● Sell	1.35M shares
61% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Jul 27, 2026 Analysis Breakdown: Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 14, 2028 Buy	Performance-based restricted stock unit	Pacitti David Chief Executive Officer	CEO / President	242 047 Value: $6.05M
Apr 14, 2028 Buy	Performance-based restricted stock unit	Pacitti David Chief Executive Officer	CEO / President	242 047 Value: $6.05M
Jul 27, 2026 Sell	Restricted Share Units D-Return	Blackford Gary Director	Director	12 003 Value: $0
Jul 27, 2026 Sell	Common Stock D-Return	Blackford Gary Director	Director	79 590 Value: $1.99M
Jul 27, 2026 Sell	Restricted Share Units D-Return	Egbuonu-davis Lisa Director	Director	12 003 Value: $0
Jul 27, 2026 Sell	Common Stock D-Return	Egbuonu-davis Lisa Director	Director	13 811 Value: $345.3K
Jul 27, 2026 Sell	Common Stock D-Return	Franchini Indrani Lall Director	Director	4 817 Value: $120.4K
Jul 27, 2026 Sell	Common Stock D-Return	Galovan Scott Michael SVP, Chief Financial Officer	C-Suite Officer	96 121 Value: $2.40M
Jul 27, 2026 Sell	Employee Stock Option (right to buy) D-Return	Galovan Scott Michael SVP, Chief Financial Officer	C-Suite Officer	21 038 Value: $320.6K
Jul 27, 2026 Buy	Common Stock A-Award	Galovan Scott Michael SVP, Chief Financial Officer	C-Suite Officer	96 121 Value: $2.40M
Jul 27, 2026 Sell	Common Stock D-Return	Delgado Sigfrido SVP, Operations	Officer	54 886 Value: $1.37M
Jul 27, 2026 Sell	Employee Stock Option (right to buy) D-Return	Delgado Sigfrido SVP, Operations	Officer	21 914 Value: $334.0K
Jul 27, 2026 Sell	Employee Stock Option (right to buy) D-Return	Delgado Sigfrido SVP, Operations	Officer	37 520 Value: $513.6K
Jul 27, 2026 Buy	Common Stock A-Award	Delgado Sigfrido SVP, Operations	Officer	54 886 Value: $1.37M
Jul 27, 2026 Sell	Employee Stock Option (right to buy) D-Return	Galovan Scott Michael SVP, Chief Financial Officer	C-Suite Officer	69 630 Value: $953.2K
Jul 27, 2026 Buy	Common Stock A-Award	Pacitti David Chief Executive Officer	CEO / President	444 730 Value: $11.1M
Jul 27, 2026 Sell	Common Stock D-Return	Pacitti David Chief Executive Officer	CEO / President	444 730 Value: $11.1M
Jul 27, 2026 Sell	Employee Stock Option (right to buy) D-Return	Pacitti David Chief Executive Officer	CEO / President	239 354 Value: $3.28M
Jul 27, 2026 Sell	Common Stock D-Return	Shimer Julie Ann Director	Director	50 090 Value: $1.25M
Jul 27, 2026 Sell	Restricted Share Units D-Return	Shimer Julie Ann Director	Director	12 003 Value: $0
Jul 27, 2026 Sell	Common Stock D-Return	Oleary Patrick J Director	Director	54 640 Value: $1.37M
Jul 27, 2026 Sell	Restricted Share Units D-Return	Oleary Patrick J Director	Director	12 003 Value: $0
Jul 27, 2026 Sell	Restricted Share Units D-Return	Franchini Indrani Lall Director	Director	12 003 Value: $0
May 08, 2026 Buy	Restricted Share Units A-Award	Shimer Julie Ann Director	Director	12 003 Value: $297.7K
May 08, 2026 Buy	Restricted Share Units A-Award	Oleary Patrick J Director	Director	12 003 Value: $297.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AVANOS MEDICAL INC.

Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed ai...

Read Full Profile Here